Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

NCT00106184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Myositis
Dermatomyositis
Polymyositis
Juvenile Dermatomyositis

Interventions

DRUG: Rituximab
DRUG: Placebo

Sponsor

University of Pittsburgh

Collaborators

[object Object]
[object Object]
[object Object]